Genmab | DEBITO



Debt Cambiamento Data
Agios Pharmaceuticals USD 0 0 2025-03
Almirall EUR 408.66M 56.36M 2024-06
Amarin USD 0 0 2024-09
Amgen USD 57.38B 2.72B 2025-03
AstraZeneca USD 31.65B 1.35B 2025-03
Bayer EUR 40.7B 465M 2024-12
BioMarin Pharmaceutical USD 595.65M 585K 2025-03
Demant DKK 15.68B 146M 2024-12
Exelixis USD 0 0 2025-01
Fresenius Medical Care EUR 10.98B 225M 2024-12
Galapagos EUR 10.86M 864K 2025-03
Genmab DKK 1.03B 42M 2024-12
GlaxoSmithKline GBP 18.43B 1.45B 2025-03
GN Store Nord DKK 11.77B 1.46B 2025-03
GRIFOLS EUR 9.23B 626.05M 2024-12
Hikma Pharmaceutical USD 1.28B 85M 2024-06
Insmed USD 1.13B 147.86M 2024-12
Lonza CHF 4.71B 915M 2024-12
Merck EUR 10.27B 1.11B 2024-12
Novartis USD 31.26B 828M 2024-12
Regeneron Pharmaceuticals USD 2.7B 400K 2025-03
Roche Holding CHF 34.44B 5.23B 2024-06
Sanofi 21.05B 3.14B 2025-03
UCB EUR 3.03B 13M 2024-12



Genmab DEBITO - Valori correnti, dati storici, previsioni, statistiche, grafici e calendario economico - May 2025.